Connect Biopharma Holdings Ltd (CNTB NASDAQ) stock market data APIs
$2.3321
0.03(1.3%)
as of May 22, 2026
Try our APIs with
free plan!
Connect Biopharma Holdings Ltd Financial Data Overview
Price chart is built with
Anychart
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
Prev. Close
2.3321
Open
2.362
High
2.4744
Low
2.3145
52 wk Range
0.73-3.82
Market Cap
132 M
Shares Outstanding
56 521 K
Revenue
233 K
EPS
-0.2695
Beta
-0.183
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Connect Biopharma Holdings Ltd data using free add-ons & libraries
Get Connect Biopharma Holdings Ltd Fundamental Data
Connect Biopharma Holdings Ltd Fundamental data includes:
- Net Revenue: 233 K
- EBITDA: -65 539 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Connect Biopharma Holdings Ltd Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-04-01
- EPS/Forecast: -0.2825
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Connect Biopharma Holdings Ltd News
New
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on trans...
Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
(RTTNews) - This week's biotech landscape witnessed regulatory approvals across the U.S., EU, and China, acquisitions, a few key trial goal misses and positive clinical trial data readouts across ther...
Connect Biopharma Shares Jump 13% After Positive Rademikibart Data And $20.2 Million Financing
(RTTNews) - Connect Biopharma Holding Limited (CNTB) surged 13% in pre-market trading Monday after the company issued three major announcements, including positive clinical data for Rademikibart in as...
Connect Reports Positive Topline Results From Phase 1 Pharmacology Study With Rademikibart
(RTTNews) - Connect Biopharma Holdings (CNTB) reported positive topline preliminary results for its Phase 1 clinical pharmacology study evaluating intravenous rademikibart, the next-generation, anti-i...
Get Connect Biopharma Holdings Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
